A randomized trial of immunotherapy for persistent genital warts

about

Progress and prospects for L2-based human papillomavirus vaccines Programmed death-1 (PD-1)-dependent functional impairment of CD4(+) T cells in recurrent genital papilloma.Genital warts treatment: Beyond imiquimod.

P2860

Q37014047-1A54C5C3-8A76-4DC9-8688-6F58654E23F5 Q42256500-C4E758D4-838D-437E-B52A-EA449D969A7E Q54262209-B98034B9-EF8B-45EB-B0F1-D64F5D4C2F2C

P2860

A randomized trial of immunotherapy for persistent genital warts

Item

http://www.wikidata.org/entity/Q36391858

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

A randomized trial of immunotherapy for persistent genital warts

@ast

A randomized trial of immunotherapy for persistent genital warts

@en

type

Item

label

A randomized trial of immunotherapy for persistent genital warts

@ast

A randomized trial of immunotherapy for persistent genital warts

@en

prefLabel

A randomized trial of immunotherapy for persistent genital warts

@ast

A randomized trial of immunotherapy for persistent genital warts

@en

P1476

A randomized trial of immunotherapy for persistent genital warts

@en

P2093

Cheryn Palmer

http://www.w3.org/2001/XMLSchema#string

David Jardine

http://www.w3.org/2001/XMLSchema#string

James Pang

http://www.w3.org/2001/XMLSchema#string

Jieqiang Lu

http://www.w3.org/2001/XMLSchema#string

John Chuah

http://www.w3.org/2001/XMLSchema#string

Quanmei Tu

http://www.w3.org/2001/XMLSchema#string

P2860

Traditional therapies for the treatment of condylomata acuminata (genital warts).

The status of HPV16-specific T-cell reactivity in health and disease as a guide to HPV vaccine development.

Preoperative immune status determines anal condyloma recurrence after surgical excision.

Prevention of cervical cancer through papillomavirus vaccination.

Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.

A guide to immunotherapy of genital warts: focus on interferon and imiquimod.

Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.

Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.

Cryotherapy for anogenital warts: factors affecting therapeutic response.

Antibodies against human papillomavirus type 6 capsids are elevated in men with previous condylomas.

P304

623-629

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.19319

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ian Frazer

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225063861

http://www.w3.org/2001/XMLSchema#string

P698

22634446

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

3495719

http://www.w3.org/2001/XMLSchema#string

A randomized trial of immunotherapy for persistent genital warts

about

P2860

P2860

A randomized trial of immunotherapy for persistent genital warts

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932